Results 221 to 230 of about 15,669 (253)

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Lancet Neurology, The, 2010
Shinichiro Uchiyama, Takenori Yamaguchi
exaly  

Cilostazol

Nihon rinsho. Japanese journal of clinical medicine, 2016
openaire   +3 more sources

Cilostazol Inhibits Oxidative Stress–Induced Premature Senescence Via Upregulation of Sirt1 in Human Endothelial Cells

Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
Masato Eto, Mitsunobu R Kano, Katsuya Iijima   +2 more
exaly  

Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase

Brain, 2014
Song Guo, Jes Olesen, Messoud Ashina
exaly  

Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity

Journal of the American College of Cardiology, 2009
Young-Hoon Jeong, Seung-Whan Lee, Choong Hwan Kwak   +2 more
exaly  

Clinical Efficacy and Safety of Cilostazol: A Critical Review of the Literature

Drugs, 2015
Kelly C Rogers, Carrie S Oliphant, Shannon W Finks   +2 more
exaly  

Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study

Lancet Neurology, The, 2008
Yining Huang, Ka Sing Wong
exaly  

Cilostazol is anti‐inflammatory in BV2 microglial cells by inactivating nuclear factor‐kappaB and inhibiting mitogen‐activated protein kinases

British Journal of Pharmacology, 2010
Cheol Park, Soo-Woong Lee, Won Sun Park
exaly  

Cilostazol Reduces Angiographic Restenosis After Endovascular Therapy for Femoropopliteal Lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol Study

Circulation, 2013
Yoshimitsu Soga, Kenji Suzuki, Yoshiaki Yokoi   +2 more
exaly  

CILOSTAZOL

2005
openaire   +1 more source